Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Ebewe Pharma GmbH

Division of Novartis AG

Latest From Ebewe Pharma GmbH

Novartis leadership reshuffle brings Biogen Idec talent to Sandoz

Jeff George, head of Novartis's generics business Sandoz since December 2008, is to take over the leadership of its eye care business Alcon. He will replace the retiring Kevin Buehler, who has been with the company for 30 years. Mr George's replacement at Sandoz is Biogen Idec's senior vice president, US commercial operations, Richard Francis.

Neurology Immune Disorders

Novartis gets FDA warning about Austrian plant

Novartis's Sandoz unit needs to get its Austrian Unterach plant in order after a US FDA warning letter detailed a number of violations, including the manufacturing and distribution of "unapprovable" finished drugs in the US.

Par Acquisition By TPG Allows Competing Marriage Proposals

Par will be acquired by private equity firm TPG in $1.9 billion deal if no other suitors come forward with a better offer over the next month.

BioPharmaceutical Deals

Sandoz Pushes Further Into High-Barrier Generics With $1.5B Acquisition of Fougera

Sandoz is acquiring the U.S. generics dermatology business Fougera, which formerly belonged to Nycomed, for $1.5 billion in cash, giving it entry into a highly profitable niche market.

BioPharmaceutical United States
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Austria
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Friedrich Hillebrand, CEO
  • Contact Info
  • Ebewe Pharma GmbH
    Phone: (43) 7665 81230
    Mondseestrasse 11
    Unterach, 4866